With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...

The data will further extend the wide-ranging evidence base for semaglutide through real-world evidence studies and additional analysis of the landmark cardiovascular outcomes trial, SELECT ...

Although enobosarm + semaglutide significantly preserved lean ... In contrast, Veru’s sabizabulin is a new molecular entity, small molecule that targets the colchicine binding site on β-tubulin.

Known as Cerro El Cono, this massive, pyramid-shaped formation is cloaked in mystery due to both its striking structure and the extreme difficulty of reaching it. The 1,310-foot-tall ...

Vivani’s lead programs, NPM-139 (semaglutide implant ... While the current GLP-1 landscape includes over 50 new molecular entities under clinical stage development, Vivani remains confident ...

The number of ligand binding sites in the dopamine transporter is enigmatic due to conflicting data from structures and molecular pharmacology. Here, force spectra reveal the position and dynamics ...

More than 100 nominees have made the final ballot for this year’s RSC elections, which will see members decide who fills 27 roles across our society. Professor Dame Sarah Gilbert, Professor Susan ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...